Invitae vs Illumina Which Is More Reliable?

Invitae and Illumina are two leading players in the genomics industry, each with its own unique strengths and opportunities for growth. Invitae is a rapidly growing company focused on genetic testing services, while Illumina is a well-established leader in DNA sequencing technology. Both companies have seen significant increases in their stock prices in recent years, but with differing strategies and market positions. Investors looking to capitalize on the rapidly expanding genomics market may find opportunities in both Invitae and Illumina stocks.

Invitae or Illumina?

When comparing Invitae and Illumina, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Invitae and Illumina.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Invitae has a dividend yield of -%, while Illumina has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Invitae reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, Illumina reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Invitae P/E ratio at -0.00 and Illumina's P/E ratio at -14.43. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Invitae P/B ratio is -0.00 while Illumina's P/B ratio is 10.76.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Invitae has seen a 5-year revenue growth of 0.00%, while Illumina's is 0.26%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Invitae's ROE at 178.89% and Illumina's ROE at -42.15%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $0.00 for Invitae and $140.29 for Illumina. Over the past year, Invitae's prices ranged from $0.00 to $1.66, with a yearly change of 331820.00%. Illumina's prices fluctuated between $97.36 and $156.66, with a yearly change of 60.90%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.